Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if AUTL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
16 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 41 days ago
Red flags: 0
84 filers reported a long position in AUTL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MAK CAPITAL ONE LLC | $53.8M | 33.6M | Unchanged |
| Blackstone Inc. | $32.8M | 20.5M | Unchanged |
| Syncona Portfolio Ltd | $26.6M | 16.6M | Unchanged |
| ARMISTICE CAPITAL, LLC | $24M | 15M | -5.1% |
| Tetragon Partners GP Ltd | $15.2M | 9.5M | Unchanged |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $12.9M | 7.8M | -17.5% |
| Frazier Life Sciences Management, L.P. | $7.1M | 4.4M | Unchanged |
| BNP Paribas Asset Management Holding S.A. | $5.4M | 3.4M | Unchanged |
| Laurion Capital Management LP | $5.3M | 3.3M | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $3.2M | 2M | -13.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.